New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Erin Park

Manager, Operations

Erin Park serves as NephCure’s Operations Manager. They received their degree in English Language and Gaelic Studies at the University of Glasgow in Scotland. Erin brings a strong background in academic program operations and editorial skills to the team. They’re passionate about creating strong infrastructure to support NephCure’s programs and staff, and they’re excited about the opportunities for innovation in patient empowerment. In their free time, they enjoy watching drag art and comedy, hanging out with their senior kitty, Ophelia, or trying new restaurants in Philadelphia and beyond.

Philadelphia, PA

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.